[Ip-health] Call for expressions of interest to become a member of expert groups on Horizon 2020 - deadline tomorrow 6 March:

Tessel Mellema tessel at haieurope.org
Mon Mar 4 12:02:51 PST 2013


I haven't seen this call yet on iphealth, so here it is, a bit late:

Call for expressions of interest to become a member of expert groups on
Horizon 2020  - deadline tomorrow 6 March:

DG Research has published a call for expressions of interest to become a
member of expert groups on Horizon 2020, please see
http://ec.europa.eu/research/horizon2020/index_en.cfm?pg=h2020-experts.

The European Commission is widening its search for experts from all
fields to participate in shaping the agenda of Horizon 2020, the
European Union's future funding programme for research and innovation.
The experts of the advisory groups will provide high quality and timely
advice for the preparation of the Horizon 2020 calls for project
proposals.  

 

The EU will need experts in the different fields of health research and
independent experts are heavily needed - also in the field of for
example IP management and innovation inducement prizes! Expressions of
interest  should be submitted no later than 6 March 2013 at 17.00,
Brussels local time (CET) to be taken into account for the setting up of
the first Horizon 2020 Advisory Groups.

 

Tessel

 

Tessel Mellema

Policy Advisor- Trade, Innovation & Access to Medicines

 

Health Action International (HAI) Europe

Overtoom 60 II, 1054 HK Amsterdam 

t. +31 20 683 3684

f. +31 20 685 5002

e. Tessel at haieurope.org <mailto:Tessel at haieurope.org>  

w. www.haieurope.org <http://www.haieurope.org/> 

 

Follow HAI Europe on Twitter <https://twitter.com/#!/HAIEurope>  or
Facebook
<https://www.facebook.com/pages/Health-Action-International-HAI-Europe/1
02588189864739>   

 

Health Action International (HAI) is an independent, global network
working to increase access to essential medicines and improve their
rational use through research excellence and evidence-based advocacy.

 

Important Email Information:

The information contained in this email is confidential and may be
legally privileged.  It is intended solely for the addressee and is for
the exclusive use of the intended recipient(s). If you are not the
intended recipient(s), please note that any form of disclosure,
distribution, copying or use of this communication or the information in
it or in any attachments is strictly prohibited and may be unlawful. If
you are not the intended addressee, please contact the sender and
dispose of this e-mail immediately. Any opinions expressed are those of
the author, not of HAI.

 




More information about the Ip-health mailing list